Minerva Neurosciences NERV
NASDAQ NERV
$2.39 -0.14 (-5.53%)
At close: Oct 21, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Capital Expenditures (2014)

Updated

Minerva Neurosciences (NERV) posted Capital Expenditures of $16,326 for FY2022.

Analysis

Minerva Neurosciences (NERV) Capital Expenditures (2014) Analysis & Trends

Since FY2013, Minerva Neurosciences has reported Capital Expenditures for 4 years.

  • Annual Capital Expenditures shows a five-year compound annual growth rate of -20.8% (FY2017 to FY2022).
  • The FY2022 figure stands as the highest annual Capital Expenditures since FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 Minerva Neurosciences 114.63 Mn -133.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 11,870.00
API Access

Minerva Neurosciences Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NERV&period=max&api_key=YOUR_API_KEY